Cargando…
Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566579/ https://www.ncbi.nlm.nih.gov/pubmed/34732798 http://dx.doi.org/10.1038/s41598-021-01575-x |
_version_ | 1784594045601841152 |
---|---|
author | Hasegawa, Hideaki Mizoguchi, Izuru Orii, Naoko Inoue, Shinya Katahira, Yasuhiro Yoneto, Toshihiko Xu, Mingli Miyazaki, Toru Yoshimoto, Takayuki |
author_facet | Hasegawa, Hideaki Mizoguchi, Izuru Orii, Naoko Inoue, Shinya Katahira, Yasuhiro Yoneto, Toshihiko Xu, Mingli Miyazaki, Toru Yoshimoto, Takayuki |
author_sort | Hasegawa, Hideaki |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8566579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85665792021-11-05 Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development Hasegawa, Hideaki Mizoguchi, Izuru Orii, Naoko Inoue, Shinya Katahira, Yasuhiro Yoneto, Toshihiko Xu, Mingli Miyazaki, Toru Yoshimoto, Takayuki Sci Rep Author Correction Nature Publishing Group UK 2021-11-03 /pmc/articles/PMC8566579/ /pubmed/34732798 http://dx.doi.org/10.1038/s41598-021-01575-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Hasegawa, Hideaki Mizoguchi, Izuru Orii, Naoko Inoue, Shinya Katahira, Yasuhiro Yoneto, Toshihiko Xu, Mingli Miyazaki, Toru Yoshimoto, Takayuki Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
title | Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
title_full | Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
title_fullStr | Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
title_full_unstemmed | Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
title_short | Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
title_sort | author correction: il-23p19 and cd5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566579/ https://www.ncbi.nlm.nih.gov/pubmed/34732798 http://dx.doi.org/10.1038/s41598-021-01575-x |
work_keys_str_mv | AT hasegawahideaki authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT mizoguchiizuru authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT oriinaoko authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT inoueshinya authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT katahirayasuhiro authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT yonetotoshihiko authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT xumingli authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT miyazakitoru authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment AT yoshimototakayuki authorcorrectionil23p19andcd5antigenlikeformapossiblenovelheterodimericcytokineandcontributetoexperimentalautoimmuneencephalomyelitisdevelopment |